Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium

GlobeNewswireDec 10 21:00

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaNov 15 05:10

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug

BenzingaNov 15 03:23

S&P 500 Moves Lower; US Crude Oil Inventories Increase

BenzingaNov 15 03:08

Dow Falls Over 100 Points; US Producer Prices Rise In October

BenzingaNov 15 01:19

H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $21

Futu NewsNov 15 00:31 · Ratings